Bridging the gap: state and private industry response to the lack of a Medicare outpatient prescription drug benefit.
Although there is considerable political momentum and public support for a Medicare outpatient prescription drug benefit, enactment of full-fledged reform will take time given the other political priorities on the legislative agenda. The article describes how various states and private initiatives have acted to increase access to affordable outpatient prescription drugs for seniors.
Goldstein
Wendy C
WC
Epstein Becker and Green, PC, New York Office, USA. wgoldstein@ebglaw.com
Peterson
Kathleen A
KA
D000368:Aged; D000553:Ambulatory Care / Q000191:economics*; D003254:Consumer Advocacy; D004608:Eligibility Determination; D006291:Health Policy / Q000331:legislation & jurisprudence; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence*; D006278:Medicare / Q000331:legislation & jurisprudence*; D011057:Politics; D011907:Rate Setting and Review; D013221:State Health Plans / Q000331:legislation & jurisprudence*; D014481:United States